<DOC>
	<DOCNO>NCT00000374</DOCNO>
	<brief_summary>This 3-year study determine antipsychotic medication olanzapine ( Zyprexa® ) risperidone ( Risperdal® ) help patient first-episode schizophrenia .</brief_summary>
	<brief_title>Treatment First-Episode Schizophrenia</brief_title>
	<detailed_description>The goal study prevent morbidity first-episode schizophrenia use second-generation antipsychotic drug : olanzapine , risperidone . Long-term study first-episode schizophrenia patient clearly indicate excellent initial responsiveness positive psychotic symptom treatment conventional antipsychotic medication . However , year immediately follow initial good response , morbidity increase . Relapses , often multiple one , rule usually precipitate medication noncompliance . There evidence second-generation antipsychotic drug may superior efficacy term outcome domain . However , new agent study primarily chronic and/or treatment-resistant patient sample virtually long-term study study compare new drug one another . First episode patient randomly assign treatment olanzapine risperidone 3 year . Outcome measure initial episode include psychopathology ( positive , negative , affective symptom ) , side effect , neurocognition ( executive function , memory , attention ) , social occupational function service utilization . The effect long-term course measure term frequency timing relapse , level recovery subsequent episodes prospectively assessed course psychopathology , neurocognitive function , social/vocational function , service utilization . For information relate study , please follow link : http : //clinicaltrials.gov/show/NCT00320671</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>First episode schizophrenia , schizophreniform disorder schizoaffective disorder Prior treatment antipsychotic medication .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Adolescence</keyword>
	<keyword>Adult</keyword>
	<keyword>Antipsychotic Agents</keyword>
	<keyword>Female</keyword>
	<keyword>Human</keyword>
	<keyword>Male</keyword>
	<keyword>olanzapine</keyword>
	<keyword>Risperidone</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Antipsychotic Agents -- *therapeutic use</keyword>
	<keyword>olanzapine -- *therapeutic use</keyword>
	<keyword>Risperidone -- *therapeutic use</keyword>
	<keyword>Schizophrenia -- *drug therapy</keyword>
</DOC>